Table 2:

Evidence for Prescribers-Choice Adherence rules and percentage adherence to each rule.

Prescribers-Choice Adherence Rules*	LOE	HTN Guideline	2006 Secondary Stroke Prevention Guideline	2011 Secondary Stroke Prevention Guideline	2014 Secondary Stroke Prevention Guideline	Threshold	% Prescribers- Choice Adherence
Use ACEi or ARB in Diabetes	A	JNC 6 1997 - present	✔	✔	✔	80%	53.4%
AA use of diuretic or CCB	A	JNC 7 2003-Present	Silent Endorses JNC7	Silent Endorses 2011 Primary Stroke	Silent Endorses 2011 Primary Stroke	80%	48.5%
Use of diuretic, ACEi/ARB or CCB	A	JNC 7 2003-Present	✔	✔	✔	80%	74.4%
BB in compelling Cardiac Indication	A	JNC 6 1997 - present	Silent Endorses JNC7	✔	✔	80%	52%
% Failed to avoid BB without Compelling	A	JNC 6 1997 - present	Silent Endorses JNC7	Silent Endorses 2011 Primary Stroke	Silent Endorses 2011 Primary Stroke	<5%	20%
Any 1 of 5 Rules Combined	A	✔	✔	✔	✔	80%	59.7%
							GP-Koch Rules

^*This is different from compliance as it focused on the preserver’s choice of antihypertensive agents rather than patient’s ability to consistently take the medication; BP-Choice Adherence: Blood Pressure medication Choice Adherence to Clinical Practice Guidelines as derived from the Sixth Joint National Commission on Hypertension and the ISH 2020 HTN Guidelines; JNC: Joint National Commission on Hypertension; AA: African Americans; ACEi: Angiotensin Enzyme Inhibitors; ARB: Angiotensin Receptor Blockers; BB: Beta Blockers; CCB: Calcium Channel Blockers.